SFM
KRSA

Sphera Funds Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Sphera Funds Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-893
Closed -$331K – 96
2020
Q1 		$331K Buy
+893
New +$63.7K 0.04% 72

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sphera Funds Management's KRSA Position: Q2 2020 in Review

Sphera Funds Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2020, closing a stake of 893 shares — an estimated $331K sold.

Sphera Funds Management first reported a position in KRSA in Q1 2020 and held it in 1 quarter. The position peaked at $331K in Q1 2020. 70 funds tracked by Wall St. Rank hold KRSA as of Q2 2020.

  • Sphera Funds Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Sphera Funds Management sold 893 Korsana Biosciences, Inc. Common Stock shares in Q2 2020, an estimated $331K.
  • Sphera Funds Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Sphera Funds Management's Korsana Biosciences, Inc. Common Stock position peaked at $331K in Q1 2020.
  • 70 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2020.

Based on Sphera Funds Management's 13F filing for Q2 2020, filed 13 Aug 2020.